Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Yijia Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in Hangzhou, China, focused on the R&D, manufacturing, and marketing of high-quality pharmaceutical products. Established in 2003, the company has developed a diverse portfolio primarily centered on anti-infectives, digestive system medications, and respiratory treatments. Yijia operates state-of-the-art GMP-certified production lines for small molecule injectables and solid dosage forms. The company is recognized as a National High-Tech Enterprise and maintains a strong distribution network throughout the Chinese domestic market. Its business model integrates drug development with large-scale manufacturing and commercialization of both generic and improved therapeutic agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yijia Pharmaceutical.